Dear Colleagues: Welcome to the April–June 2021 edition of Innovations in Clinical Neuroscience (ICNS). For 2021’s second quarterly issue of ICNS, we start with the case report of a 76-year-old
Dear Colleagues: Welcome to the January–March 2021 edition of Innovations in Clinical Neuroscience (ICNS). For 2021’s first quarterly issue of ICNS, we start with two letters to the editor. In
Dear Colleagues: Welcome to the October–December 2020 edition of Innovations in Clinical Neuroscience (ICNS). For 2020’s fourth and final quarterly issue of ICNS, we start with a letter to the
Dear Colleagues: Welcome to the July–September 2020 edition of Innovations in Clinical Neuroscience (ICNS). For 2020’s third quarterly issue of ICNS, we start with two letters to the editor. First,
Dear Colleagues: Welcome to the April–June 2020 edition of Innovations in Clinical Neuroscience (ICNS). For 2020’s second quarterly issue of ICNS, we start with original research by Azizi et al
Dear Colleagues: Welcome to the January–March 2020 edition of Innovations in Clinical Neuroscience (ICNS). I’d first like to inform our readers that starting this year, ICNS will move from a
Dear Colleagues: Welcome to the November–December 2019 edition of Innovations in Clinical Neuroscience (ICNS). The issue begins with a case report by Diaz et al titled, “Use of Noninvasive Ventilation
Dear Colleagues: Welcome to the September–October 2019 edition of Innovations in Clinical Neuroscience (ICNS). We start this issue with a study titled, “Psychiatric Comorbidities in Adult Attention-deficit/Hyperactivity Disorder: Prevalence and
Dear Colleagues: Welcome to the July–August 2019 edition of Innovations in Clinical Neuroscience (ICNS). We start this issue with a meta-analysis by Whitlock, Woodward, and Alexander titled, “Is High Placebo
Dear Colleagues: Welcome to the May-June 2019 edition of Innovations in Clinical Neuroscience (ICNS). In this issue, we revisit the topic of postpartum depression in men with a review article
Dear Colleagues: Welcome to the March–April 2019 issue of Innovations in Clinical Neuroscience (ICNS). We start this issue with a Psychotherapy Rounds submission titled, “Addiction Disorder Considerations in Patients Seeking
Dear Colleagues: Welcome to the January–February 2019 issue of Innovations in Clinical Neuroscience (ICNS). We start this issue with a review article by Yeo et al titled, “Virtual Reality Neurorehabilitation
Dear Colleagues: Welcome to the November–December issue of Innovations in Clinical Neuroscience (ICNS). We start this issue with an article by Aboraya et al titled “Measurement-based Care in Psychiatry—Past, Present,
Dear Colleagues: Welcome to the September–October 2018 issue of Innovations in Clinical Neuroscience (ICNS). We start this issue with a systematic review by Bart et al titled, “The Assessment and
Dear Colleagues: Welcome to the July–August 2018 issue of Innovations in Clinical Neuroscience (ICNS). We start this issue with a report by Brennan et al titled, “Implementation of the Electronic
Dear Colleagues: Welcome to the May–June 2018 issue of Innovations in Clinical Neuroscience (ICNS). We start the issue with a timely review article by Touma and Scarff titled, “Valbenazine and
Dear Colleagues: Welcome to the March–April 2018 issue of Innovations in Clinical Neuroscience (ICNS). We are excited to lead this edition of ICNS with an exciting commentary by Dr. Michael
Dear Colleagues: Welcome to the January-February 2018 issue of Innovations in Clinical Neuroscience (ICNS). This is a milestone year for us as it marks the beginning of our 15th year
Dear Colleagues: Welcome to the May-June 2017 issue of Innovations in Clinical Neuroscience. We start the issue with the review article, “The Role and Treatment Implications of Peripheral and Central
Dear Colleagues: Welcome to the March–April 2017 issue of Innovations in Clinical Neuroscience. We start this issue with an interesting case series by Shroff titled, “Human Embryonic Stem Cells in
Innov Clin Neurosci. 2017;14(3–4):11 Dear Editor: Traumatic brain injury (TBI) is a significant cause of morbidity and mortality. Annually, more than two million people in the United States will sustain
Dear Colleagues: Welcome to the January–February 2017 issue of Innovations in Clinical Neuroscience. We start our 14th year of publication strong with an interesting and diverse issue we hope you
Dear Colleagues: Welcome to the November–December 2016 issue of Innovations in Clinical Neuroscience. We begin this issue with a thoughtful review and commentary by Calabró et al titled, “The Right
Dear Colleagues: Welcome to the September-October 2016 issue of Innovations in Clinical Neuroscience (ICNS). As the official journal of the CNS Summit, the International Society for CNS Drug Development (ISCDD),
Dear Colleagues: Welcome to the July–August 2016 issue of Innovations in Clinical Neuroscience. We start this issue with an interesting study by MacEwan et al titled, “Pharmaceutical Innovation in the
Dear Colleagues: Welcome to the May–June 2016 issue of Innovations in Clinical Neuroscience. I am pleased to start the issue with the first of a series of articles we’ll be
Dear Colleagues: Welcome to the March–April 2016 issue of Innovations in Clinical Neuroscience (ICNS). Attitudes regarding marijuana use have changed dramatically over the past 50-plus years in the United States.
Dear Colleagues: Welcome to the January–February 2016 issue of Innovations in Clinical Neuroscience. We start this issue with the article “Erectile Dysfunction in Individuals with Neurologic Disability: A Hospital-based Cross-sectional
Dear Colleagues: Welcome to the November–December 2015 issue of Innovations in Clinical Neuroscience. First, I would like to call your attention to the accompanying supplement to this issue of the
Dear Colleagues: Welcome to the September–October 2015 issue of Innovations in Clinical Neuroscience. We start this issue with an intriguing review by Yarlagadda et al titled,“Placental Barrier and Autism Spectrum
Dear Colleagues: Welcome to the July–August 2015 issue of Innovations in Clinical Neuroscience. We begin this issue with a review article by Cole et al titled, “Efficacy of Transcranial Magnetic
Dear Colleagues: Welcome to the May-June issue of Innovations in Clinical Neuroscience. First, I would like to call your attention to the accompanying supplement to this issue of the journal,
Dear Colleagues: Welcome to the March–April 2015 issue of Innovations in Clinical Neuroscience (ICNS). First, I would like to call to your attention the supplement that accompanies this issue of
Dear Colleagues: Twice a year, the International Society for CNS Clinical Trials and Methodology (ISCTM) brings together academic researchers, policy makers, and industry and government representatives to focus on promoting
Dear Colleagues: Welcome to the January-February 2015 issue of Innovations in Clinical Neuroscience and to the beginning of our 12th year of publication. Over the years, we have sought to
Dear Colleagues: Welcome to the November–December 2014 issue of Innovations in Clinical Neuroscience. We start this issue with the first of what we hope to be a series of drug
Dear Colleagues: Every year, over 800,000 people commit suicide worldwide, with over 40,000 of these deaths occurring annually in the United States. There are many more who attempt it.[1,2] A
Dear Colleagues: Welcome to the July-August issue of Innovations in Clinical Neuroscience. We start this issue with an original research article titled, “Transcultural Adaptation of GRID Hamilton Rating Scale For
Dear Colleagues: Welcome to the May-June issue of Innovations in Clinical Neuroscience. This month we open with an interesting contribution by Lehrer and Lorenze titled “Anosognosia in Schizophrenia: Hidden in
Dear Colleagues: Welcome to the March–April issue of Innovations in Clinical Neuroscience. In this issue, we are pleased to introduce a new commentary series on the communication of clinical trial
Dear Colleagues: Welcome to the January-February 2014 issue of Innovations in Clinical Neuroscience.
Dear Colleagues: Welcome to the November-December issue of Innovations in Clinical Neuroscience.
Dear Colleagues: Welcome to the September–October issue of Innovations in Clinical Neuroscience. We start with a study by El-Ibiary et al titled, “A Pilot Study Evaluating Genetic and Environmental Factors
Dear Colleagues: Welcome to the July–August 2013 issue of Innovations in Clinical Neuroscience.
Dear Colleagues: Welcome to the May–June 2013 issue of Innovations in Clinical Neuroscience.
Dear Colleagues: Welcome to the April issue of Innovations in Clinical Neuroscience. This month, we lead with a topic we are covering for the first time in the journal and
Dear Colleagues: Welcome to the March 2013 issue of Innovations in Clinical Neuroscience. We start this issue with a study by Vilhauer et al titled, “Improving Quality of Life for
Welcome to the February issue of Innovations in Clinical Neuroscience. We start this issue with a study by Shiovitz et al in which the authors report the results of the
Dear Colleagues: Welcome to the January issue of Innovations in Clinical Neuroscience and to our tenth year of publication. This month, we lead with our “Ethics in Psychiatry” column titled,
Dear Colleagues: Welcome to the November–December issue of Innovations in Clinical Neuroscience.
Welcome to the October issue of Innovations in Clinical Neuroscience.
Dear Colleagues: Welcome to the September issue of Innovations in Clinical Neuroscience. In this issue, we are pleased to present
Dear Colleagues: Welcome to the July-August issue of Innovations in Clinical Neuroscience. We hope everyone enjoyed a relaxing summer spent with family and friends. We start this issue of the
Dear Colleagues: Welcome to the May-June issue of Innovations in Clinical Innovations. In this issue of the journal, we start with two articles on adult attention deficit hyperactivity disorder (ADHD).
Dear Colleagues: Welcome to the April issue of Innovations in Clinical Neuroscience. In this issue, we offer two interesting articles that touch on schizophrenia. In a review article by
Dear Colleagues: Welcome to the March issue of Innovations in Clinical Neuroscience. Innovation in neuroscience may not always be demonstrated in the creation of a novel drug or technologically advanced
Dear Colleagues: Welcome to the February issue of Innovations in Clinical Neuroscience. Psychiatry continues to be a core focus of the journal, and so I am always pleased when
Dear Colleagues: Welcome to the January issue of Innovations in Clinical Neuroscience. As usual, we cover a variety of topics within the neuroscience field this month, and we hope you
Welcome to the December issue of Innovations in Clinical Neuroscience.
Dear Colleagues: Welcome to the November issue of Innovations in Clinical Neuroscience.
Dear Colleagues: Welcome to the October 2011 issue of Innovations in Clinical Neuroscience.
Welcome to the September issue of Innovations in Clinical Neuroscience.
Dear Colleagues: Welcome to the August issue of Innovations in Clinical Neuroscience.
Dear Colleagues: Welcome to the July issue of Innovations in Clinical Neuroscience.
Dear Colleagues: Welcome to the June issue of Innovations in Clinical Neuroscience.
Dear Colleagues: Welcome to the May issue of Innovations in Clinical Neuroscience.
Dear Colleagues: Welcome to the March issue of Innovations in Clinical Neuroscience.
Dear Colleagues: Welcome to the February 2011 issue of Innovations in Clinical Neuroscience.
Dear Colleagues: Welcome to the January issue of Innovations in Clinical Neuroscience, our first issue under our new title. We have a diverse issue this month, and we hope you
Dear Colleagues: Welcome to the December issue of Psychiatry 2010. We hope you all are enjoying the holiday season and are looking forward to a healthy, happy 2011. As you
Dear Colleagues: Welcome to the November issue of Psychiatry 2010.
Dear Colleagues: Welcome to the September issue of Psychiatry 2010. We hope everyone had a restful and relaxing summer and is ready for the cooler weather and the busy months
Dear Colleagues: Welcome to the July issue of Psychiatry 2010. We start this issue with Trend Watch, in which the authors provide information on patient-reported side effects from a cross-section
Dear Colleagues: Welcome to the March issue of Psychiatry 2010. In this month’s “Trend Watch,” the authors explore the penetration of generic atypical antipsychotics in the United States market before
Dear Colleagues: Welcome to the February issue of Psychiatry 2010. As you are all very aware, the recent study in JAMA by Fournier et al on antidepressant drug effects and
Dear Colleagues: Goodbye 2009; hello Psychiatry 2010! As we ring in the ‘Ten,’ we of course update the journal’s name to reflect the new year. But what is the journal’s
